Mesterolone

Proviron, also known as Mesterolone, is a renowned anabolic androgenic steroid with a rich history. Developed by Schering Pharmaceuticals, Proviron offers unique benefits that make it a valuable compound for post-cycle therapy (PCT).

During PCT, one of the main goals is to stimulate natural testosterone production and rebalance hormone levels. While Proviron is not typically considered a primary agent for this purpose, it can still play a role in PCT for the following reasons: 1. Estrogen control: Proviron has a weak affinity for the aromatase enzyme, which can help prevent the conversion of testosterone into estrogen. By controlling estrogen levels, it can aid in minimizing the risk of estrogen-related side effects during PCT. 2. SHBG binding: Proviron has a high affinity for sex hormone-binding globulin (SHBG), which can reduce SHBG’s ability to bind to testosterone. This can potentially increase the levels of free testosterone, which is the biologically active form that can interact with androgen receptors. While Proviron can offer benefits in PCT, it is important to note that it is not as commonly used as other compounds such as selective estrogen receptor modulators (SERMs) like Clomid (Clomiphene) or Nolvadex (Tamoxifen). These SERMs are generally considered the primary agents for stimulating natural testosterone production and rebalancing hormone levels in PCT.